Ortataxel | Interleukin Related interleukin-related.com

Product Name :
Ortataxel

Search keywords :
Ortataxel

drugId :
null

Target Vo:
Tubulin

Target Vo Short Name :
Tubulin

Moa_Name:
Tubulin inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Indena

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Lymphoma, Non-Hodgkin

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ROCK1 Antibody
Phospho-eIF4G (Ser1108) Antibody
RUNX2 Antibody: RUNX2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to RUNX2. It can be used for ICC/IF,IHC-P,WB assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts